SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Global Blood Therapeutics Q1 EPS $(1.200) Beats $(1.510) Estimate, Sales $14.118M Beat $3.490M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.200) per share which beat the analyst consensus estimate of $(1.510) by 20.53 percent. This is a 37.93 percent decrease over losses of $(0.870) per

Benzinga · 05/06/2020 20:36

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.200) per share which beat the analyst consensus estimate of $(1.510) by 20.53 percent. This is a 37.93 percent decrease over losses of $(0.870) per share from the same period last year. The company reported quarterly sales of $14.118 million which beat the analyst consensus estimate of $3.490 million by 304.53 percent.